The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity
Abstract Mitochondrial-derived peptides (MDPs) and their analogs have emerged as wide-spectrum, stress response factors protective in amyloid disease models. MDP cytoprotective functions are generally attributed to anti-apoptotic activity, however, little is known about their capacity to facilitate...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f99bdda07fa499097deb4fdc1230f9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0f99bdda07fa499097deb4fdc1230f9a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0f99bdda07fa499097deb4fdc1230f9a2021-12-02T11:40:42ZThe Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity10.1038/s41598-017-08372-52045-2322https://doaj.org/article/0f99bdda07fa499097deb4fdc1230f9a2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08372-5https://doaj.org/toc/2045-2322Abstract Mitochondrial-derived peptides (MDPs) and their analogs have emerged as wide-spectrum, stress response factors protective in amyloid disease models. MDP cytoprotective functions are generally attributed to anti-apoptotic activity, however, little is known about their capacity to facilitate the cell’s unfolded protein response via direct interactions with amyloidogenic proteins. Here, we explored the effects of the MDP-analog, humaninS14G (HNG), and the MDP, small humanin-like peptide 2 (SHLP2), on the misfolding of islet amyloid polypeptide (IAPP), a critical pathogenic step in type 2 diabetes mellitus (T2DM). Our thioflavin T fluorescence studies show that HNG inhibits IAPP misfolding at highly substoichiometric concentrations. Seeded fluorescence and co-sedimentation studies demonstrate MDPs block amyloid seeding and directly bind misfolded, seeding-capable IAPP species. Furthermore, our electron paramagnetic resonance spectroscopy and circular dichroism data indicate MDPs do not act by binding IAPP monomers. Taken together our results reveal a novel chaperone-like activity wherein these MDPs specifically target misfolded amyloid seeds to inhibit IAPP misfolding which, along with direct anti-apoptotic activity and beneficial metabolic effects, make HNG and SHLP2 exciting prospects as T2DM therapeutics. These data also suggest that other mitochondrial stress response factors within the MDP family may be amenable to development into therapeutics for protein-misfolding diseases.Alan K. OkadaKazuki TeranishiFleur LoboJ. Mario IsasJialin XiaoKelvin YenPinchas CohenRalf LangenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Alan K. Okada Kazuki Teranishi Fleur Lobo J. Mario Isas Jialin Xiao Kelvin Yen Pinchas Cohen Ralf Langen The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity |
description |
Abstract Mitochondrial-derived peptides (MDPs) and their analogs have emerged as wide-spectrum, stress response factors protective in amyloid disease models. MDP cytoprotective functions are generally attributed to anti-apoptotic activity, however, little is known about their capacity to facilitate the cell’s unfolded protein response via direct interactions with amyloidogenic proteins. Here, we explored the effects of the MDP-analog, humaninS14G (HNG), and the MDP, small humanin-like peptide 2 (SHLP2), on the misfolding of islet amyloid polypeptide (IAPP), a critical pathogenic step in type 2 diabetes mellitus (T2DM). Our thioflavin T fluorescence studies show that HNG inhibits IAPP misfolding at highly substoichiometric concentrations. Seeded fluorescence and co-sedimentation studies demonstrate MDPs block amyloid seeding and directly bind misfolded, seeding-capable IAPP species. Furthermore, our electron paramagnetic resonance spectroscopy and circular dichroism data indicate MDPs do not act by binding IAPP monomers. Taken together our results reveal a novel chaperone-like activity wherein these MDPs specifically target misfolded amyloid seeds to inhibit IAPP misfolding which, along with direct anti-apoptotic activity and beneficial metabolic effects, make HNG and SHLP2 exciting prospects as T2DM therapeutics. These data also suggest that other mitochondrial stress response factors within the MDP family may be amenable to development into therapeutics for protein-misfolding diseases. |
format |
article |
author |
Alan K. Okada Kazuki Teranishi Fleur Lobo J. Mario Isas Jialin Xiao Kelvin Yen Pinchas Cohen Ralf Langen |
author_facet |
Alan K. Okada Kazuki Teranishi Fleur Lobo J. Mario Isas Jialin Xiao Kelvin Yen Pinchas Cohen Ralf Langen |
author_sort |
Alan K. Okada |
title |
The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity |
title_short |
The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity |
title_full |
The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity |
title_fullStr |
The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity |
title_full_unstemmed |
The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity |
title_sort |
mitochondrial-derived peptides, humanins14g and small humanin-like peptide 2, exhibit chaperone-like activity |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/0f99bdda07fa499097deb4fdc1230f9a |
work_keys_str_mv |
AT alankokada themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT kazukiteranishi themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT fleurlobo themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT jmarioisas themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT jialinxiao themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT kelvinyen themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT pinchascohen themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT ralflangen themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT alankokada mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT kazukiteranishi mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT fleurlobo mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT jmarioisas mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT jialinxiao mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT kelvinyen mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT pinchascohen mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity AT ralflangen mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity |
_version_ |
1718395562803331072 |